Laura Sutcliffe
Stock Analyst at Citi
(2.40)
# 3,042
Out of 5,070 analysts
503
Total ratings
50.3%
Success rate
0.9%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: COH Cochlear Limited | Reiterated: Hold | $140.00 | $139.95 | +0.04% | 19 | Oct 19, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $180.00 | $196.41 | -8.35% | 45 | Oct 19, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $31.00 | $14.68 | +111.17% | 41 | Oct 19, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Hold | $34.00 | $34.96 | -2.75% | 26 | Oct 18, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $225.00 | $184.18 | +22.17% | 9 | Sep 23, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $39.50 | $46.26 | -14.60% | 17 | Sep 10, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $49.00 | $54.10 | -9.43% | 18 | Sep 10, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $22.00 | $18.76 | +17.30% | 17 | Sep 10, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $27.73 | $21.10 | +31.44% | 7 | Sep 10, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Upgraded: Buy | $51.00 | $49.39 | +3.26% | 9 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 → $240 | $245.50 | -2.24% | 15 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €40.00 → €34.00 | €27.18 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 86.00 → CHF 84.00 | CHF 126.50 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | €73.58 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.13 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 1,850p → 1,820p | 1,869p | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $39.07 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $153.64 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $869.72 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $84 → $86 | $30.75 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €108.00 | €146.40 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $41.40 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.63 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $303 → $300 | $39.35 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,283.66 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $61.68 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $156.51 | n/a | 14 | Oct 18, 2017 |
Cochlear Limited
Oct 19, 2026
Reiterated: Hold
Price Target: $140.00
Current: $139.95
Upside: +0.04%
CSL Limited
Oct 19, 2026
Reiterated: Hold
Price Target: $180.00
Current: $196.41
Upside: -8.35%
Telix Pharmaceuticals Limited
Oct 19, 2026
Reiterated: Buy
Price Target: $31.00
Current: $14.68
Upside: +111.17%
ResMed Inc.
Oct 18, 2026
Reiterated: Hold
Price Target: $34.00
Current: $34.96
Upside: -2.75%
Pro Medicus Limited
Sep 23, 2026
Reiterated: Buy
Price Target: $225.00
Current: $184.18
Upside: +22.17%
Ansell Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $39.50
Current: $46.26
Upside: -14.60%
Ramsay Health Care Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $49.00
Current: $54.10
Upside: -9.43%
Sonic Healthcare Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $22.00
Current: $18.76
Upside: +17.30%
EBOS Group Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $27.73
Current: $21.10
Upside: +31.44%
Fisher & Paykel Healthcare Corporation Limited
Sep 10, 2026
Upgraded: Buy
Price Target: $51.00
Current: $49.39
Upside: +3.26%
Sep 10, 2026
Reiterated: Hold
Price Target: $235 → $240
Current: $245.50
Upside: -2.24%
May 7, 2024
Reiterated: Hold
Price Target: €40.00 → €34.00
Current: €27.18
Upside: n/a
Dec 14, 2022
Reiterated: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: CHF 126.50
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: €73.58
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $13.13
Upside: n/a
Aug 8, 2022
Reiterated: Hold
Price Target: 1,850p → 1,820p
Current: 1,869p
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $39.07
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $153.64
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $869.72
Upside: n/a
Apr 12, 2021
Reiterated: Hold
Price Target: $84 → $86
Current: $30.75
Upside: n/a
Feb 28, 2020
Reiterated: Hold
Price Target: €108.00
Current: €146.40
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $41.40
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $50.63
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: $303 → $300
Current: $39.35
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,283.66
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $61.68
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $156.51
Upside: n/a